<code id='CBC46B76AD'></code><style id='CBC46B76AD'></style>
    • <acronym id='CBC46B76AD'></acronym>
      <center id='CBC46B76AD'><center id='CBC46B76AD'><tfoot id='CBC46B76AD'></tfoot></center><abbr id='CBC46B76AD'><dir id='CBC46B76AD'><tfoot id='CBC46B76AD'></tfoot><noframes id='CBC46B76AD'>

    • <optgroup id='CBC46B76AD'><strike id='CBC46B76AD'><sup id='CBC46B76AD'></sup></strike><code id='CBC46B76AD'></code></optgroup>
        1. <b id='CBC46B76AD'><label id='CBC46B76AD'><select id='CBC46B76AD'><dt id='CBC46B76AD'><span id='CBC46B76AD'></span></dt></select></label></b><u id='CBC46B76AD'></u>
          <i id='CBC46B76AD'><strike id='CBC46B76AD'><tt id='CBC46B76AD'><pre id='CBC46B76AD'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:469
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.
          Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

          RichardDrew/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Idaho abortion case may prompt more restrictions in other states

          DrewAngerer/GettyImagesTheU.S.SupremeCourt’sdecisiontoconsiderthelegalityofIdaho’sabortionlaw—andtor